Tomtebodavägen 23A
Solna 112 76
Sweden
46 86 97 20 00
https://www.sobi.com
Setor(es): Healthcare
Indústria: Drug Manufacturers - Specialty & Generic
Funcionários Integrais: 1.772
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Dr. Guido Oelkers | CEO & President | 25,82M | N/A | 1965 |
Mr. Henrik Stenqvist | Chief Financial Officer | N/A | N/A | 1967 |
Mr. Torbjörn Hallberg | General Counsel & Head of Legal Affairs | N/A | N/A | 1969 |
Mr. Daniel Rankin | Head of Strategy & Corporate Development | N/A | N/A | 1980 |
Ms. Lena Bjurner | Head of Human Resources | N/A | N/A | 1968 |
Mr. Armin Reininger M.D., Ph.D. | Senior Scientific & Medical Advisor | N/A | N/A | 1957 |
Mr. Norbert Oppitz | Head of International | N/A | N/A | 1967 |
Mr. Sofiane Fahmy | Head of Europe | N/A | N/A | 1972 |
Mr. Duane H. Barnes | Head of North America | N/A | N/A | 1960 |
Mr. Mahmood Ladha | Head of Strategic Transformation Operations | N/A | N/A | 1964 |
O QualityScore de governança da ISS da Swedish Orphan Biovitrum AB (publ) a partir de 1 de abril de 2024 é 2. As principais pontuações para Auditoria são: 3; Conselho: 4; Direitos de Acionistas: 1; Compensação: 2.